Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2012

01-05-2012 | Article

Comparative evaluation of Vitek 2 identification and susceptibility testing of Gram-negative rods directly and isolated from BacT/ALERT-positive blood culture bottles

Authors: M. J. Munoz-Dávila, G. Yagüe, M. Albert, T. García-Lucas

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2012

Login to get access

Abstract

The performance of Vitek 2 was evaluated for the identification and susceptibility testing of Gram-negative bacilli directly from positive blood cultures bottles. Direct inoculation of the positive blood cultures with the Vitek cards ID-GN and AST-NO58 was compared with the standard inoculation method based on the sub-culture of the positive blood culture to agar. A total of 142 blood cultures were included in the study; of those, 119 were from patients’ clinical samples, while 23 were artificially prepared with strains showing different mechanisms of resistance. A total of 136 (95.8%) strains were correctly identified to the species level, only 2 (1.4%) were mis-identified and 4 (2.8%) were not identified. Susceptibility results were available for all isolates tested against 17 antibiotics, thus, resulting in a total of 2,414 isolate/anti-microbial combinations. The error rate was 2.8% (67/2,414) overall; 0.6% (14/2,414) very major errors, 0.1% (3/2,414) major errors and 2.1% (50/2,414) minor errors. The direct method detected 88.5% (22/25) of the strains producing extended-spectrum beta-lactamases (ESBLs). The susceptibility agreement among the added strains with ESBL, AMPc hyperproduction, resistance to ceftazidime, carbapenems and cefepime was very high. Direct identification and susceptibility testing gave rapid and reliable results, reducing by 24 h the turnaround time of the microbiology laboratory.
Literature
1.
go back to reference Barenfanger J, Drake C, Kacich G (1999) Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 37:1415–1418PubMed Barenfanger J, Drake C, Kacich G (1999) Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 37:1415–1418PubMed
2.
go back to reference Doern GV, Vautour R, Gaudet M, Levy B (1994) Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 32:1757–1762PubMed Doern GV, Vautour R, Gaudet M, Levy B (1994) Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 32:1757–1762PubMed
3.
go back to reference Kerremans JJ, Verboom P, Stijnen T, Hakkaart-van Roijen L, Goessens W, Verbrugh HA, Vos MC (2008) Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother 61:428–435PubMedCrossRef Kerremans JJ, Verboom P, Stijnen T, Hakkaart-van Roijen L, Goessens W, Verbrugh HA, Vos MC (2008) Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother 61:428–435PubMedCrossRef
4.
go back to reference Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) (1999) Manual of clinical microbiology, 7th edn. American Society for Microbiology, Washington, D.C. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) (1999) Manual of clinical microbiology, 7th edn. American Society for Microbiology, Washington, D.C.
5.
go back to reference Christner M, Rohde H, Wolters M, Sobottka I, Wegscheider K, Aepfelbacher M (2010) Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption–ionization time of flight mass spectrometry fingerprint. J Clin Microbiol 48:1584–1591PubMedCrossRef Christner M, Rohde H, Wolters M, Sobottka I, Wegscheider K, Aepfelbacher M (2010) Rapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption–ionization time of flight mass spectrometry fingerprint. J Clin Microbiol 48:1584–1591PubMedCrossRef
6.
go back to reference Ferroni A, Suarez S, Beretti JL, Dauphin B, Bille E, Meyer J, Bougnoux ME, Alanio A, Berche P, Nassif X (2010) Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 48:1542–1548PubMedCrossRef Ferroni A, Suarez S, Beretti JL, Dauphin B, Bille E, Meyer J, Bougnoux ME, Alanio A, Berche P, Nassif X (2010) Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 48:1542–1548PubMedCrossRef
7.
go back to reference Prod’hom G, Bizzini A, Durussel C, Bille J, Greub G (2010) Matrix-assisted laser desorption ionization–time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J Clin Microbiol 48:1481–1483PubMedCrossRef Prod’hom G, Bizzini A, Durussel C, Bille J, Greub G (2010) Matrix-assisted laser desorption ionization–time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J Clin Microbiol 48:1481–1483PubMedCrossRef
8.
go back to reference Stevenson LG, Drake SK, Murray PR (2010) Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 48:444–447PubMedCrossRef Stevenson LG, Drake SK, Murray PR (2010) Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 48:444–447PubMedCrossRef
9.
go back to reference Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E (2005) Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med 165:1375–1380PubMedCrossRef Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E (2005) Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern Med 165:1375–1380PubMedCrossRef
11.
go back to reference Bruins MJ, Bloembergen P, Ruijs GJ, Wolfhagen MJ (2004) Identification and susceptibility testing of Enterobacteriaceae and Pseudomonas aeruginosa by direct inoculation from positive BACTEC blood culture bottles into Vitek 2. J Clin Microbiol 42:7–11PubMedCrossRef Bruins MJ, Bloembergen P, Ruijs GJ, Wolfhagen MJ (2004) Identification and susceptibility testing of Enterobacteriaceae and Pseudomonas aeruginosa by direct inoculation from positive BACTEC blood culture bottles into Vitek 2. J Clin Microbiol 42:7–11PubMedCrossRef
12.
go back to reference de Cueto M, Ceballos E, Martínez-Martínez L, Perea EJ, Pascual A (2004) Use of positive blood cultures for direct identification and susceptibility testing with the Vitek 2 system. J Clin Microbiol 42:3734–3738PubMedCrossRef de Cueto M, Ceballos E, Martínez-Martínez L, Perea EJ, Pascual A (2004) Use of positive blood cultures for direct identification and susceptibility testing with the Vitek 2 system. J Clin Microbiol 42:3734–3738PubMedCrossRef
13.
go back to reference Hansen DS, Jensen AG, Nørskov-Lauritsen N, Skov R, Bruun B (2002) Direct identification and susceptibility testing of enteric bacilli from positive blood cultures using VITEK (GNI+/GNS-GA). Clin Microbiol Infect 8:38–44PubMedCrossRef Hansen DS, Jensen AG, Nørskov-Lauritsen N, Skov R, Bruun B (2002) Direct identification and susceptibility testing of enteric bacilli from positive blood cultures using VITEK (GNI+/GNS-GA). Clin Microbiol Infect 8:38–44PubMedCrossRef
14.
go back to reference Ling TK, Tam PC, Liu ZK, Cheng AF (2001) Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates. J Clin Microbiol 39:2964–2966PubMedCrossRef Ling TK, Tam PC, Liu ZK, Cheng AF (2001) Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates. J Clin Microbiol 39:2964–2966PubMedCrossRef
15.
go back to reference Ling TK, Liu ZK, Cheng AF (2003) Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures. J Clin Microbiol 41:4705–4707PubMedCrossRef Ling TK, Liu ZK, Cheng AF (2003) Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures. J Clin Microbiol 41:4705–4707PubMedCrossRef
16.
go back to reference Quesada MD, Giménez M, Molinos S, Fernández G, Sánchez MD, Rivelo R, Ramírez A, Banqué G, Ausina V (2010) Performance of VITEK-2 Compact and overnight MicroScan panels for direct identification and susceptibility testing of Gram-negative bacilli from positive FAN BacT/ALERT blood culture bottles. Clin Microbiol Infect 16:137–140PubMedCrossRef Quesada MD, Giménez M, Molinos S, Fernández G, Sánchez MD, Rivelo R, Ramírez A, Banqué G, Ausina V (2010) Performance of VITEK-2 Compact and overnight MicroScan panels for direct identification and susceptibility testing of Gram-negative bacilli from positive FAN BacT/ALERT blood culture bottles. Clin Microbiol Infect 16:137–140PubMedCrossRef
17.
go back to reference Chen JR, Lee SY, Yang BH, Lu JJ (2008) Rapid identification and susceptibility testing using the VITEK 2 system using culture fluids from positive BacT/ALERT blood cultures. J Microbiol Immunol Infect 41:259–264PubMed Chen JR, Lee SY, Yang BH, Lu JJ (2008) Rapid identification and susceptibility testing using the VITEK 2 system using culture fluids from positive BacT/ALERT blood cultures. J Microbiol Immunol Infect 41:259–264PubMed
18.
go back to reference Joyanes P, del Carmen Conejo M, Martínez-Martínez L, Perea EJ (2001) Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J Clin Microbiol 39(9):3247–3253PubMedCrossRef Joyanes P, del Carmen Conejo M, Martínez-Martínez L, Perea EJ (2001) Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J Clin Microbiol 39(9):3247–3253PubMedCrossRef
19.
go back to reference Gavin PJ, Warren JR, Obias AA, Collins SM, Peterson LR (2002) Evaluation of the Vitek 2 system for rapid identification of clinical isolates of gram-negative bacilli and members of the family Streptococcaceae. Eur J Clin Microbiol Infect Dis 21:869–874PubMed Gavin PJ, Warren JR, Obias AA, Collins SM, Peterson LR (2002) Evaluation of the Vitek 2 system for rapid identification of clinical isolates of gram-negative bacilli and members of the family Streptococcaceae. Eur J Clin Microbiol Infect Dis 21:869–874PubMed
20.
go back to reference Wiegand I, Geiss HK, Mack D, Stürenburg E, Seifert H (2007) Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol 45:1167–1174PubMedCrossRef Wiegand I, Geiss HK, Mack D, Stürenburg E, Seifert H (2007) Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol 45:1167–1174PubMedCrossRef
Metadata
Title
Comparative evaluation of Vitek 2 identification and susceptibility testing of Gram-negative rods directly and isolated from BacT/ALERT-positive blood culture bottles
Authors
M. J. Munoz-Dávila
G. Yagüe
M. Albert
T. García-Lucas
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1356-1

Other articles of this Issue 5/2012

European Journal of Clinical Microbiology & Infectious Diseases 5/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.